Pain News and Research

Latest Pain News and Research

Enrollment complete in Diamyd Phase II study for type 1 diabetes

A total of 50 children aged four and older with a high risk of developing type 1 diabetes have been enrolled in a researcher-initiated Phase II study, DiAPREV-IT, with Diamyd Medical's diabetes vaccine Diamyd. The study is thus fully recruited.

9 Jan 2012

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

Bristol-Myers Squibb Company and Inhibitex, Inc. announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger.

8 Jan 2012

Americans cutting costs by skipping prescription drugs

A Consumer Reports survey revealed that more Americans are ignoring their doctor’s advice and skipping prescription drugs or medical procedures to save money in 2011 than a year earlier.

8 Jan 2012

Great Prostate Cancer Challenge 5K Race to take place in Fort Myers on Jan. 28

Lace up your sneakers and join Florida Urology Physicians and ZERO — The Project to End Prostate Cancer on Saturday, January 28, 2012 for the Great Prostate Cancer Challenge 5K Race in Fort Myers. The Great Prostate Cancer Challenge is America's premier men's health event series, taking place in 33 cities in 2012.

7 Jan 2012

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants - reflecting a broad range of activity.

From Medtronic 7 Jan 2012

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

We stumbled upon this news a couple weeks back regarding Cannabis Science, Inc. reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.

7 Jan 2012

IQWiG study finds considerable added benefit of abiraterone in prostate cancer patients

Abiraterone has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel.

7 Jan 2012

USPTO issues patent to Tris Pharma's OralXR+ platform

Tris Pharma, an emerging specialty pharmaceutical company, announced the US grant of its core technology patent for its OralXR+ platform. This is the first patent grant of a substantial estate filed by Tris Pharma and covers a multitude of actives having modified release formulations comprising drug-ion exchange resin complexes.

7 Jan 2012

CMS assigns permanent J-code for Savient's KRYSTEXXA to treat RCG

Savient Pharmaceuticals, Inc. today announced that a product-specific billing code, or permanent J-code, for KRYSTEXXA (pegloticase) became available on January 1, 2012.

7 Jan 2012

KAI commences enrollment in KAI-4169 second Phase 2 study for CKD-MBD

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced initiation of patient enrollment in the second Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients with secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease.

6 Jan 2012

Endo enters global development agreement with BDSI for BEMA Buprenorphine

Endo Pharmaceuticals announced today it has signed a worldwide license and development agreement with U.S.-based BioDelivery Sciences International for BEMA Buprenorphine.

6 Jan 2012

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).

6 Jan 2012

Endo, BDSI partner to develop and commercialize BEMA Buprenorphine for chronic pain

BioDelivery Sciences International, Inc. today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain.

6 Jan 2012

UCSF appeals USPTO panel judgment in favor of InSite Vision

InSite Vision Incorporated today announced that the University of California, San Francisco (UCSF) has appealed the judgment of the United States Patent and Trademark Office (USPTO) panel that found in favor of the Company in its patent interference litigation with UCSF.

6 Jan 2012

Sanofi granted preliminary injunction to prevent launch of Seikagaku's Synvisc-One

Sanofi US today announced that the U. S. District Court in Massachusetts granted the company a preliminary injunction against a Synvisc-One (hylan G-F 20) competitor product developed by Seikagaku Corporation.

6 Jan 2012

Experts share 10 symptoms of cervical and other gynecologic cancers

Pelvic pain and abnormal bleeding aren't the only signs of gynecologic cancer. As part of Cervical Health Awareness Month in January, experts at The University of Texas MD Anderson Cancer Center share other symptoms that often are overlooked.

6 Jan 2012

UPV/EHU lecturer looks at how the act of dying is handled in children's picture books

How do you tell a little girl that her grandfather, her mother, her friend- has died, and that he or she has gone for ever? Txabi Arnal, a lecturer at the University of the Basque Country (UPV/EHU), has analysed literary picture books that deal with death to see how they address this question.

5 Jan 2012

One in six patients experience deterioration in quality of life after oesophageal cancer surgery

A new study published in the Journal of Clinical Oncology shows that most patients who survive for at least five years after oesophageal cancer surgery recover an average quality of life. However, quality of life deteriorates significantly for one in six patients to a level that remains much lower than the average population in the five years after surgery.

5 Jan 2012

Special issue explores military applications of acupuncture

The current issue of Medical Acupuncture, a peer-reviewed journal published by Mary Ann Liebert, Inc., explores how the U.S. military is incorporating medical acupuncture to assist in the medical care of military personnel serving in the war zones and the efforts underway to explore military applications of acupuncture.

5 Jan 2012

Married patients benefit from herniated spinal disc surgery

Some patient subgroups see greater improvement after surgery for herniated spinal discs relative to nonoperative outcomes—notably including married patients whose symptoms are getting worse, reports a study in the January 15, 2012, issue of Spine.

5 Jan 2012

Pain News and Research

Latest Pain News and Research

Enrollment complete in Diamyd Phase II study for type 1 diabetes

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

Americans cutting costs by skipping prescription drugs

Great Prostate Cancer Challenge 5K Race to take place in Fort Myers on Jan. 28

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

IQWiG study finds considerable added benefit of abiraterone in prostate cancer patients

USPTO issues patent to Tris Pharma's OralXR+ platform

CMS assigns permanent J-code for Savient's KRYSTEXXA to treat RCG

KAI commences enrollment in KAI-4169 second Phase 2 study for CKD-MBD

Endo enters global development agreement with BDSI for BEMA Buprenorphine

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

Endo, BDSI partner to develop and commercialize BEMA Buprenorphine for chronic pain

UCSF appeals USPTO panel judgment in favor of InSite Vision

Sanofi granted preliminary injunction to prevent launch of Seikagaku's Synvisc-One

Experts share 10 symptoms of cervical and other gynecologic cancers

UPV/EHU lecturer looks at how the act of dying is handled in children's picture books

One in six patients experience deterioration in quality of life after oesophageal cancer surgery

Special issue explores military applications of acupuncture

Married patients benefit from herniated spinal disc surgery

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in